Increasing Access to Transplantation for the Highly Sensitized Patient: Combining the Latest Innovations in HLA Typing, Antibody Detection and Data Analysis
We explore how the evolution of more efficient NGS workflows and advanced Single Antigen assays with extended allele coverage can improve analysis with Epitope Matching and Virtual Crossmatching. Together, these tools and technologies are bringing new opportunities for highly sensitized patients to receive life-saving transplants. Recorded live at the ASHI 2020 Virtual Event.
Other ASHI 2020 Videos
© 2025 Thermo Fisher Scientific Inc. All rights reserved.